An LC-MS/MS method for simultaneous analysis of the cystic fibrosis therapeutic drugs colistin, ivacaftor and ciprofloxacin
Inhaled antibiotics such as colistin and ciprofloxacin are increasingly used to treat bacterial lung infections in cystic fibrosis patients. In this study, we established and validated a new HPLC-MS/MS method that could simultaneously detect drug concentrations of ciprofloxacin, colistin and ivacaft...
Main Authors: | Huiya Yuan, Shihui Yu, Guihong Chai, Junting Liu, Qi (Tony) Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-12-01
|
Series: | Journal of Pharmaceutical Analysis |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2095177921000198 |
Similar Items
-
Simultaneous Quantification of Ivacaftor, Tezacaftor, and Elexacaftor in Cystic Fibrosis Patients’ Plasma by a Novel LC–MS/MS Method
by: Federica Pigliasco, et al.
Published: (2023-02-01) -
Pancreatitis in A Patient with Cystic Fibrosis Taking Ivacaftor
by: Argyri Petrocheilou, et al.
Published: (2020-01-01) -
Ivacaftor: A Novel Mutation Modulating Drug
by: Harit Kapoor, et al.
Published: (2014-11-01) -
Analysis of Ivacaftor drug approval for cystic fibrosis patients with gating mutations.
by: Nemirajaiah, S.
Published: (2021-08-01) -
Ivacaftor in cystic fibrosis adults: Czech experience with six years of follow-up
by: Libor Fila, et al.
Published: (2016-06-01)